The probe provides NIR-II imaging and multimodal measurement of CTGF in the brains of early-stage AD mice when the CTGF expression level is significantly higher than that of wild-type control and no significant Aβ plaque appears. The gene discussed is CCN2; the disease is Alzheimer disease.